Abstract:
The present specification discloses methods of detecting a contaminant of interest in a sample, components useful in carrying out these methods, including PCR primers and a detection solution and kits thereof.
Abstract:
The present inventions relates to a polypeptide, preferably a dimer and/or hexamer thereof, more preferably a dimer, comprising a sequence selected from the group comprising SEQ ID NO1, SEQ ID NO2, SEQ ID NO3, SEQ ID NO4, SEQ ID NO5, SEQ ID NO6, SEQ ID NO7, SEQ ID NO8, SEQ ID NO19 and SEQ ID NO9 or a variant thereof, preferably SEQ ID NO1 or a variant thereof, for the diagnosis of a disease, a diagnostically useful carrier comprising a means for specifically capturing an antibody to SEQ ID N01 in a sample from a subject, a kit comprising the diagnostically useful carrier, and a method, preferably for diagnosing a disease, comprising the step detecting in a sample from a subject the presence or absence of an antibody to SEQ ID NO1.
Abstract translation:本发明涉及多肽,优选其二聚体和/或六聚体,更优选二聚体,其包含选自下组的序列:SEQ ID NO1,SEQ ID NO2,SEQ ID NO3, SEQ ID NO4,SEQ ID NO5,SEQ ID NO6,SEQ ID NO7,SEQ ID NO8,SEQ ID NO19和SEQ ID NO9或其变体,优选SEQ ID NO1或其变体,用于诊断疾病,诊断 其包含用于特异性捕获来自受试者的样品中的SEQ ID NO:1的抗体的工具,包含该诊断上有用的载体的试剂盒以及优选用于诊断疾病的方法,该方法包括在来自受试者的样品中检测 存在或不存在针对SEQ ID NO1的抗体。 p>
Abstract:
The present invention provides a combination of genomic and computational technologies to provide rapid, portable sample analysis for sequencing or identifying a target sequence involving generating probes for use in analyzing a sample which may comprise a target sequence.
Abstract:
This invention provides a system of providing and creating personalized immunotherapeutic compositions for a subject having a disease or condition, including therapeutic immunotherapy delivery vectors and methods of making the same comprising gene expression constructs expressing peptides associated with one or more neo-epitopes or peptides containing mutations that are specific to a subject's cancer or unhealthy tissue. A delivery vector of this invention includes bacterial vectors including Listeria bacterial vectors; or viral vectors, peptide immunotherapy vectors; or DNA immunotherapy vectors, comprising one or more fusion proteins comprising one or more peptides comprising one or more neo-epitopes present in disease-bearing biological samples obtained from the subject. This invention also provides methods of using the same for inducing an immune response against a disease or condition, including a tumor or cancer, or an infection, or an autoimmune disease or an organ transplant rejection in the subject.
Abstract:
Provided herein is technology relating to sequencing nucleic acids and particularly, but not exclusively, to devices, methods, and systems for sequencing-by-synthesis using changes in pH to monitor base addition. In some embodiments the electrochemical hydrogen ion sensor is a microfabricated mixed metal oxide electrode and in some embodiments the electrochemical hydrogen ion sensor is a membrane electrode. Moreover, in some embodiments the device further comprises a reference electrode. Performing the sequencing reaction involves moving solutions and other fluids (e.g., samples, nucleotide solutions, wash solutions) into and out of the reaction vessel. Thus, in some embodiments, the device further comprises a tube or other transport mechanism or pathway attached t the reaction vessel.
Abstract:
Disclosed are compositions and methods related to modulation of K ATP channels and methods of treating liver disorders by modulating K ATP and mito-K ATP channels.
Abstract:
La présente invention concerne un procédé d'identification d'un virus présent dans un échantillon biologique et/ou un prélèvement clinique de patient contenant un virus dans un organisme ou cellule hôte, par comparaison du spectre obtenu par spectrométrie de masse avec les spectres d'une banque de spectres de référence de virus connu.
Abstract:
Disclosed herein is a rapid and universal assay for the detection of antigen- specific antibodies in biological samples. The assay allows for the detection of antigen-specific antibodies in any species, including species for which secondary antibodies or antisera have not been developed or are not available. Biological samples to be tested are directly labeled, such as with biotin, and contacted with antigen-bound microp articles. The presence of antigen-specific antibodies in the biological samples is detected using a binding partner for the label, such as a biotin binding partner, conjugated to a detectable label, such as a fluorophore. This improved test provides a total antibody assay that is capable of detecting all classes of antibodies simultaneously.
Abstract:
The invention relates to a method of identifying a subject having, or at risk of developing, an infectious disease state wherein endothelial integrity is compromised comprising: (a) determining a test ANG-1 level in a sample from a subject; and (b) comparing the test ANG-1 level to a control level wherein lower test ANG-1 level compared to the control level is indicative of the subject developing said infectious disease state.
Abstract:
Provided herein is a photonic bandgap (PBG) detector effective to detect inorganic molecules, organic biomolecules or biopolymers, cells, subcellular organelles, and particles. The PBG detector utilizes photonic crystals having a binding agent attached to channel surfaces comprising the crystals to selectively bind a molecule, cell or particle of interest so that an increase in light transmission is detectably induced within the photonic bandgap upon binding. Also provided are methods of optically detectiing an analyte and of identifying the presence of a cell or a particle in a biological sample.